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Two recent reports on the structures of cobalamin riboswitches uncover amazing details on how a ubiquitous riboswitch class selectively grips a large and ancient coenzyme, revealing that some variants in this class have evolved to detect a different metabolite target.
A decade ago, the first experimental validations of metabolite-binding riboswitches were reported [1] [2] [3] [4] . In those early papers, it was either implied or openly proposed that riboswitchlike molecules were probably present in early forms of life. These primeval 'RNA world' riboswitches would have served both as chemical sensors and as regulatory elements, long before proteins evolved. If many riboswitches indeed descended from RNA-based life forms, then two new publications 5, 6 provide us with spectacular views of a deluxe genetic device from the RNA world that still thrives in modern bacteria.
More than two dozen riboswitch types are now known 7 , but the class whose members sense and respond to derivatives of cobalamin (Cbl or vitamin B 12 ) is special for several reasons. When first validated as riboswitches 1 , representative 'B 12 box' RNAs from Escherichia coli and Salmonella typhimurium were shown to bind preferentially to the vitamin B 12 derivative called adenosylcobalamin (AdoCbl). Without the aid of proteins, these RNAs bind AdoCbl very precisely and very tightly, demonstrating the hallmarks of most other riboswitch classes subsequently discovered. Soon thereafter, an intriguing collection of Cbl-riboswitch variants was discovered in some organisms 8 , and its representatives appeared either to use an alternative RNA aptamer structure to bind a portion of AdoCbl or to have adapted to respond to a different Cbl derivative. Regardless, members of this Cbl-riboswitch superfamily now appear to be more common than those of any other riboswitch class. This widespread distribution is consistent with the fact that Cbl-derived co enzymes are of ancient origin and are ever present and critical in most species.
The smallest known riboswitch aptamer (for the modified nucleobase called preQ 1 ) can be formed from fewer than 35 nucleotides 9 , whereas the aptamer domains of most riboswitch classes are typically fewer than 100 nucleotides. In stark contrast, most Cbl-riboswitch aptamers are formed from 200 nucleotides or more. Thus, Cbl riboswitch aptamers are big, and if sheer size were not sufficient to deter RNA-structural biologists from pursuing X-ray structures of Cbl riboswitches, the extreme instability of AdoCbl under ambient light conditions seemed certain to confound even the boldest researchers for decades. However, the size and complexity of Cbl riboswitches also meant that they were sure to hold some surprises regarding their structure and function. Through a combination of skill and persistence, Peselis and Serganov 5 and Johnson et al. 6 have forced these RNAs to give up their structural secrets at atomic resolution, and they have uncovered some very intriguing details. Although AdoCbl is the largest metabolite known to be recognized by a riboswitch, it is still tiny compared to the size of the RNA that binds it. So what is all this ancient RNA sequence and structure doing?
Not surprisingly, some of the most conserved segments of the aptamers form a binding pocket for the coenzyme. However, ligand recognition is achieved almost exclusively by van der Waals interactions between the nucleotides forming the pocket and the various moieties appended to the corrin ring. Because this riboswitch class is so common and controls genes whose products are involved in cobalamin biosynthesis, it is surprising that ligand recognition does not include extensive the adenosine moiety in this region that otherwise forms hydrogen bonds to AdoCbl. A shift in the location of this adenosine causes a steric clash with Cbl derivatives carrying large substituents (Fig. 1, right) , and therefore AqCbl is selectively bound by these variants.
With these structures in hand, those interested in developing riboswitch-targeting antibiotics have a form of heads-up display to aid them in designing novel ligands. Also, these structures make it even more enjoyable to speculate about what B 12 -using ribozymes from the RNA world might have looked like. As noted above, the structures of the binding pockets of AdoCbl and AqCbl riboswitches differ in the J6-3 region, which sits astride the hemisphere of coenzyme B 12 that is the reactive part of the molecule. Thus, in a hypothetical ribozyme ancestor, substrates for methylation, reduction or various rearrangement reactions promoted by the coenzyme 10 would need to approach the corrin ring through the space currently occupied by J6-3. Interestingly, it is this precise region that can adopt different conformations when selectively binding AdoCbl or AqCbl. Moreover, the large accessory substructures in certain AdoCbl variants are in the vicinity of J6-3, which demonstrates that a great diversity of RNA sequences and shapes could be accommodated near the reactive face of the coenzyme. Could it be that ancient ribozymes used co enzyme B 12 by forming a binding pocket much like this modern riboswitch? Such ribozymes might even have catalyzed the reduction reaction necessary to convert RNA nucleotides into their DNA counterparts, by holding substrates near the region where J6-3 is today. Other ribozymes hydrogen bonding, which would help reduce the chance that the riboswitch would misfire by binding to the wrong metabolite. Perhaps some organisms indeed have evolved to produce natural products that trick Cbl riboswitches, but none have been discovered so far. Also, there is only one superfamily of Cbl riboswitches known, and so this single major solution to the problem of sensing Cbl is quite successful. Therefore, the findings to date suggest that this mostly 'hand-in-glove' binding strategy used by Cbl riboswitches is more than adequate to survive through eons of evolution.
Structures of the more common Cbl-riboswitch type reveal that they form two hydrogen bonds between the adenosyl moiety of AdoCbl and an adenosine of the aptamer J6-3 region (Fig. 1,  left) . These interactions rely on the precise conformation of J6-3, which is assisted by the extensive substructures carried by this aptamer type. These interactions establish ligand specificity for AdoCbl, and therefore representatives of this type are called AdoCbl riboswitches.
Johnson et al. 6 also present both biochemical and genetic evidence indicating that the variant riboswitch type favors binding aquocobalamin (AqCbl), wherein the adenosyl moiety of the coenzyme is replaced by water. The authors reason that certain organisms exposed to high light intensities, such as marine bacteria, would have an advantage by sensing the more stable AqCbl derivative. Although the J6-3 sequence contains the same consensus sequence in both riboswitch types, AqCbl riboswitches carry distinct accessory substructures that alter the conformation of Intimate liaison with SR proteins brings exon junction complexes to unexpected places
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Exon junction complexes (EJCs) are deposited on mRNAs during splicing and are key regulators of the post-transcriptional fate of messenger ribonucleoprotein particles (mRNPs). Two recent papers reporting on the transcriptome-wide mapping of EJC-binding sites in human cells reveal an unexpected heterogeneity of EJC distribution on mRNAs and a tight network of EJC-SR protein interactions contributing to the formation of a higher-order, compacted mRNP structure.
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The tetrameric core of the EJC consists of the DEAD-box RNA helicase eIF4AIII, the heterodimer Y14-MAGOH and MLN51 (also known as Barentsz), and it appears to bind RNA in a sequence-independent manner [2] [3] [4] . The EJC core interacts dynamically with additional proteins, which reflects its role in diverse cellular functions such as mRNA export, localization, translation and degradation 5, 6 . Elegant in vitro studies using nuclear extracts and reporter transcripts demonstrated that EJCs are deposited 24 nucleo tides (nt) upstream of exon-exon junctions during splicing 1 , and very recently, the PRP19-associated protein CWC22 was shown to escort eIF4AIII to the spliceosome and n e w s a n d v i e w s npg
